Palatin Technologies (PTN) Tops Q1 EPS by 1c

Go back to Palatin Technologies (PTN) Tops Q1 EPS by 1c

Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

November 14, 2023 7:30 AM EST

Enrollment Complete in Phase 3 PL9643 MELODY-1 Study in Dry Eye Disease (DED) 570 Patients EnrolledTopline Data Currently Expected Late 4Q Calendar Year 2023Phase 2 Clinical Study of Oral PL8177 in Patients with Ulcerative Colitis Interim Analysis Targeted for 1Q Calendar Year 2024Topline Results Currently Expected in 2Q Calendar Year 2024Vyleesi®Gross Product Revenue Increased 11% Over the Prior QuarterNet Product Revenue Increased 20% Over the Prior QuarterPrescriptions Dispensed Increased 14% Over the Prior... More